1. Home
  2. BDX vs CCEP Comparison

BDX vs CCEP Comparison

Compare BDX & CCEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDX
  • CCEP
  • Stock Information
  • Founded
  • BDX 1897
  • CCEP 1986
  • Country
  • BDX United States
  • CCEP United Kingdom
  • Employees
  • BDX N/A
  • CCEP N/A
  • Industry
  • BDX Medical/Dental Instruments
  • CCEP Beverages (Production/Distribution)
  • Sector
  • BDX Health Care
  • CCEP Consumer Staples
  • Exchange
  • BDX Nasdaq
  • CCEP Nasdaq
  • Market Cap
  • BDX 49.0B
  • CCEP 42.7B
  • IPO Year
  • BDX 1962
  • CCEP 1987
  • Fundamental
  • Price
  • BDX $168.50
  • CCEP $92.57
  • Analyst Decision
  • BDX Buy
  • CCEP Buy
  • Analyst Count
  • BDX 9
  • CCEP 7
  • Target Price
  • BDX $231.50
  • CCEP $90.83
  • AVG Volume (30 Days)
  • BDX 2.5M
  • CCEP 1.9M
  • Earning Date
  • BDX 08-07-2025
  • CCEP 08-06-2025
  • Dividend Yield
  • BDX 2.46%
  • CCEP 2.40%
  • EPS Growth
  • BDX 14.07
  • CCEP N/A
  • EPS
  • BDX 5.16
  • CCEP 3.19
  • Revenue
  • BDX $20,867,000,000.00
  • CCEP $21,159,540,332.00
  • Revenue This Year
  • BDX $9.30
  • CCEP $6.14
  • Revenue Next Year
  • BDX $4.88
  • CCEP $3.58
  • P/E Ratio
  • BDX $32.76
  • CCEP $28.99
  • Revenue Growth
  • BDX 5.84
  • CCEP 11.67
  • 52 Week Low
  • BDX $163.33
  • CCEP $71.49
  • 52 Week High
  • BDX $251.99
  • CCEP $94.74
  • Technical
  • Relative Strength Index (RSI)
  • BDX 36.87
  • CCEP 58.28
  • Support Level
  • BDX $171.70
  • CCEP $91.94
  • Resistance Level
  • BDX $176.33
  • CCEP $94.74
  • Average True Range (ATR)
  • BDX 2.91
  • CCEP 1.46
  • MACD
  • BDX 0.47
  • CCEP -0.05
  • Stochastic Oscillator
  • BDX 6.67
  • CCEP 54.12

About BDX Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

About CCEP Coca-Cola Europacific Partners plc

CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and South-East Asia.In 2024, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke's largest bottler, Coca-Cola Femsa sold over 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.

Share on Social Networks: